PHI with Reclus' disease (Fibrocystic Breast Disease)
How does this condition affect your private health insurance?
Reclus-Krankheit, more commonly known as Fibrocystic Breast Disease, is a benign condition characterized by changes in the breast tissue, leading to lumps, pain, and tenderness. It's extremely common, affecting over half of all women, primarily those between 20 and 50 years old. Symptoms often worsen before menstruation and may include palpable cysts or a lumpy, rope-like texture. While generally harmless, the changes can sometimes make breast self-examination challenging and may cause significant discomfort. Diagnosis typically involves clinical examination, mammography, ultrasound, and sometimes biopsy to rule out malignancy. Management focuses on symptom relief.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to several weeks, often cyclical with the menstrual cycle.
Duration of Illness (Lifetime)
Chronic and recurrent, typically lasting for many years or until menopause.
Cost of Treatment (Initial)
Several hundred to a few thousand USD for diagnosis and initial management (e.g., consultation, imaging).
Cost of Treatment (Lifetime)
Several thousand to tens of thousands USD over a lifetime due to recurrent symptoms, ongoing monitoring, and potential repeat diagnostics.
Mortality Rate
Negligible, as it is a benign condition and not directly life-threatening.
Risk of Secondary Damages
Moderate probability of psychological distress (anxiety about breast cancer) and chronic physical discomfort or pain.
Probability of Full Recovery
High probability of effective symptom management; however, complete disappearance of fibrocystic changes is less common until menopause.
Underlying Disease Risk
Low probability; fibrocystic changes are common and generally not indicative of other serious underlying systemic diseases.